Fatty infiltration of the liver means that fat, primarily in the form of triglycerides, has built up inside your liver cells beyond normal levels. A healthy liver contains some fat, but when fat accounts for more than 5% of the liver’s weight, it’s classified as hepatic steatosis, the medical term for a fatty liver. This condition affects more than 30% of the global population, making it the most common chronic liver disease in the world.
You might see this phrase on an ultrasound or imaging report after a routine checkup or bloodwork flagged something unusual. In most cases, fatty infiltration is linked to metabolic factors like excess weight, high blood sugar, or abnormal cholesterol levels. The good news: early-stage fatty liver is reversible with lifestyle changes.
What Happens Inside the Liver
Your liver constantly processes fats. It takes in fatty acids from your bloodstream, builds new fat molecules internally, burns fat for energy, and packages fat into particles that get shipped out to the rest of your body. Fatty infiltration develops when this system falls out of balance: too much fat coming in or being created, and not enough being burned or exported.
The excess triglycerides get stored inside liver cells in structures called lipid droplets. These droplets form within the cell’s internal membranes and can grow larger as more fat accumulates. In mild cases, a scattering of liver cells contain small droplets. In severe cases, fat-filled droplets crowd the cells so heavily that they push the cell’s nucleus to the side and the liver visibly changes in texture and size. This accumulation is what shows up as a bright or “echogenic” liver on an ultrasound.
Common Causes and Risk Factors
The vast majority of fatty liver cases are tied to metabolic health. The condition was recently renamed from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease, or MASLD, to better reflect its root causes. Under the updated definition, a diagnosis requires fatty liver plus at least one cardiometabolic risk factor:
- Increased waist circumference (thresholds vary by ethnicity and sex)
- Elevated blood sugar or a diabetes diagnosis
- High triglycerides
- Low HDL cholesterol (the “good” cholesterol)
- Elevated blood pressure
Having three or more of these qualifies as metabolic syndrome, and fatty liver is increasingly considered its liver-specific manifestation. Insulin resistance is the thread connecting most of these factors. When your cells respond poorly to insulin, your body stores more fat in places it normally wouldn’t, including the liver.
Heavy alcohol use is the other major cause of fatty infiltration. Even moderate drinking over time can lead to fat accumulation, and alcohol-related fatty liver is diagnosed separately from metabolic fatty liver.
Medications That Can Trigger Fatty Liver
Certain drugs can cause or worsen fatty infiltration. Corticosteroids (often prescribed for inflammation or autoimmune conditions) promote fat storage and insulin resistance. Tamoxifen, used in breast cancer treatment, and methotrexate, used for autoimmune diseases, can both cause fat buildup and even liver inflammation over time. Valproic acid, a seizure and mood-stabilizing medication, is another well-known culprit. Some chemotherapy drugs, including certain HIV medications, have also been linked to fatty liver. If you’re on a long-term medication and your imaging shows fatty infiltration, the drug itself may be contributing.
How Fatty Liver Is Detected and Graded
Fatty infiltration is most often discovered incidentally during an abdominal ultrasound ordered for another reason. On ultrasound, a fatty liver appears brighter than normal because the fat reflects sound waves more intensely. Radiologists grade what they see on a three-point scale:
- Grade 1 (mild): The liver looks slightly brighter than normal, but deeper structures like blood vessel walls and the diaphragm are still clearly visible.
- Grade 2 (moderate): Increased brightness with reduced visibility of those deeper structures.
- Grade 3 (severe): The liver is so bright that the blood vessel walls and diaphragm are nearly or completely obscured.
A more precise tool is a FibroScan, which uses a specialized ultrasound technique to measure both fat content and liver stiffness (a sign of scarring). The fat measurement, called a CAP score, is reported in decibels per meter. A CAP score above 290 dB/m generally indicates advanced fat accumulation. The stiffness measurement helps determine whether the fat has progressed to cause fibrosis, with readings above 12 kPa suggesting significant scarring.
Blood tests can also raise suspicion. Elevated liver enzymes (ALT and AST) are common clues, though many people with fatty liver have completely normal bloodwork, which is why imaging is essential for diagnosis.
Why It Matters: Stages of Progression
Simple fatty liver, where fat is present but inflammation is minimal, carries a relatively low risk on its own. Most people with this stage never develop serious liver problems. The concern is what can come next.
In roughly 20% to 30% of cases, ongoing fat accumulation triggers inflammation and damage to liver cells. This more advanced stage, now called metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH), is where real harm begins. Inflamed liver cells eventually die and get replaced by scar tissue, a process called fibrosis. Left unchecked, fibrosis can progress to cirrhosis, where so much scarring accumulates that the liver can no longer function properly. Cirrhosis also raises the risk of liver cancer.
The progression from simple fatty liver to cirrhosis typically takes years or even decades, and not everyone progresses. But because fatty liver rarely causes symptoms in its early stages, many people don’t know they have it until significant damage has already occurred. Fatigue and a dull ache in the upper right abdomen are the most commonly reported symptoms, though plenty of people feel nothing at all.
Treatment and Reversal
Weight loss is the single most effective treatment for metabolic fatty liver. Losing just 5% of your body weight is associated with roughly a 25% reduction in liver fat as measured by MRI. Sustained weight loss of 7% to 10% can improve not only the fat content but also inflammation and early-stage scarring. This makes fatty liver one of the few liver conditions that can genuinely be reversed through lifestyle changes alone.
No specific diet has been proven superior, but a Mediterranean-style eating pattern (rich in vegetables, whole grains, fish, nuts, and olive oil, with limited processed foods and added sugars) has the strongest evidence behind it. Reducing fructose and refined carbohydrates is particularly relevant, since excess sugar drives the liver’s internal fat production. Regular physical activity helps even when the number on the scale doesn’t change much, because exercise independently improves insulin sensitivity and reduces liver fat.
For people with advanced fatty liver and significant scarring, the FDA approved semaglutide (the same compound in Wegovy) in 2024 as the first medication specifically for MASH with moderate-to-advanced fibrosis. It works primarily through weight loss, along with other mechanisms that appear to reduce liver inflammation and scarring. This approval marked a turning point, since previously there were no FDA-approved drugs for the condition.
Alcohol reduction matters regardless of the underlying cause. Even if your fatty liver is metabolic in origin, alcohol adds extra stress to already-burdened liver cells and accelerates damage.
What Your Report Means for You
If your imaging report mentions fatty infiltration, the finding itself is extremely common and, at early stages, not an emergency. What matters is context: your metabolic health, your weight trajectory, whether inflammation or scarring is also present, and whether there’s an identifiable cause like medication or alcohol use.
A Grade 1 finding with normal liver enzymes and no metabolic risk factors is a very different situation from a Grade 3 finding with elevated enzymes and diabetes. The first might just need monitoring. The second calls for active intervention. In either case, the condition is telling you something about your overall metabolic health, and addressing the underlying drivers (insulin resistance, excess weight, inactivity, poor diet) benefits far more than just your liver. The same metabolic dysfunction that causes fatty liver also raises your risk of heart disease, which remains the leading cause of death in people with this condition.